Altre lingue Knight Therapeutics Inc. OTC Markets

Azioni

KHTRF

CA4990531069

Mercato chiuso - OTC Markets Altri mercati azionari 21:58:18 28/06/2024			Variaz. 5gg	Var. 1 gen.
4,15 ^USD	+4,53%		-0,24%	+4,80%

09/05	Knight Therapeutics sale di quasi il 3% dopo l'annuncio dell'accordo di fornitura e distribuzione per il farmaco ADHD; nonostante un Q1 contrastato	MT
09/05	Transcript : Knight Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Knight Therapeutics Up Near 3% After Announcing Supply and Distribution Agreement For ADHD Medication; Despite Mixed Q1	09/05
Knight Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Knight Therapeutics Brief: Q1 Net loss was $4.546 Million; Revenues were $86.604 Million	09/05
Knight Therapeutics Brief: Entering into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM In Canada and Latin America	09/05
Thérapeutique Knight déclare ses résultats du premier trimestre de 2024	09/05
Knight Therapeutics Reports First Quarter 2024 Results	09/05
Thérapeutique Knight conclut une entente exclusive d’approvisionnement et de distribution avec Ironshore Pharmaceuticals & Development, Inc. pour JORNAY PM® pour le Canada et l’Amérique latine	09/05
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for JORNAY PM® for Canada and Latin America	09/05
Knight Therapeutics Inc. Reconfirms Earnings Guidance for the Year 2024	09/05
Knight Therapeutics Enters into Exclusive Supply and Distribution Agreement with Ironshore Pharmaceuticals & Development, Inc. for Jornay Pm® for Canada and Latin America	09/05
Thérapeutique Knight annonce les résultats du vote de l’assemblée générale annuelle	09/05
Knight Therapeutics Inc. announces voting results from the Annual General Meeting	09/05
Knight Therapeutics Inc. announces voting results from the Annual General Meeting	09/05
Knight présentera à la conférence sur la santé internationale de 2024 de RBC Marchés des Capitaux à New York	07/05
Knight to Present at the 2024 RBC Capital Markets Global Healthcare Conference in New York City	07/05
Avis de conférence téléphonique de Thérapeutique Knight sur ses résultats du premier trimestre 2024	02/05
Notice of Knight Therapeutics' First Quarter 2024 Results Conference Call	02/05
Knight présentera à la conférence des investisseurs en santé Bloom Burton & Co. 2024	09/04
Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference	09/04
Thérapeutique Knight inc. se mérite une place à la cinquième édition du classement Women Lead Here du Globe and Mail sur la diversité des femmes cadres	28/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Knight Therapeutics Inc. OTC Markets

Azioni

KHTRF

CA4990531069

Altre lingue

Filtri